Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Bridgewater, NJ
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bridgewater, NJ
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Brooklyn, NY
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Brooklyn, NY
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Cincinnati, OH
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Cincinnati, OH
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
New York Methodist Hospital
mi
from
Brooklyn, NY
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
New York Methodist Hospital
mi
from
Brooklyn, NY
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Fort Worth, TX
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Worth, TX
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Burlington, VT
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Burlington, VT
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Seattle, WA
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Seattle, WA
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Clinical Research Facility
mi
from
Burlington, WI
A Study in Relapse Prevention of Treatment-resistant Depression
A Study to Assess the Long-Term Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Fluoxetine Only in the Relapse Prevention of Stabilized Patients With Treatment-Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Burlington, WI
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Lincoln Medical Center
mi
from
Lincoln, NE
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Lincoln Medical Center
mi
from
Lincoln, NE
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Sacramento, CA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Sacramento, CA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Denver, CO
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Denver, CO
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Cromwell, CT
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Cromwell, CT
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Boca Raton, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Boca Raton, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Chicago, IL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Chicago, IL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Wichita, KA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Wichita, KA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Baltimore, MD
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Baltimore, MD
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Sheppard Pratt Health System
mi
from
Baltimore, MD
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Sheppard Pratt Health System
mi
from
Baltimore, MD
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Manhasset, NY
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Manhasset, NY
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Raleigh, NC
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Raleigh, NC
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Cleveland, OH
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Cleveland, OH
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Portland, OR
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Portland, OR
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Pittsburgh, PA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Pittsburgh, PA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Lincoln, RI
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Lincoln, RI
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Dallas, TX
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Dallas, TX
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Bellevue, WA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Bellevue, WA
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With Chronic Obstructive Pulmonary Disease (COPD)
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With COPD
Status: Archived
Geriatric Medical Associates
mi
from
Brooksville, FL
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With Chronic Obstructive Pulmonary Disease (COPD)
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With COPD
Status: Archived
Updated: 1/1/1970
Geriatric Medical Associates
mi
from
Brooksville, FL
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With Chronic Obstructive Pulmonary Disease (COPD)
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With COPD
Status: Archived
Valley Medical Center
mi
from
Renton, WA
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With Chronic Obstructive Pulmonary Disease (COPD)
The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With COPD
Status: Archived
Updated: 1/1/1970
Valley Medical Center
mi
from
Renton, WA
Brain Imaging of Quetiapine Response in Anxious Depression
Brain Imaging of Quetiapine Response in Anxious Depression
Status: Archived
Indiana University Adult Psychiatry Clinic
mi
from
Indianapolis, IN
Brain Imaging of Quetiapine Response in Anxious Depression
Brain Imaging of Quetiapine Response in Anxious Depression
Status: Archived
Updated: 1/1/1970
Indiana University Adult Psychiatry Clinic
mi
from
Indianapolis, IN
rTMS for Adolescents and Young Adults
rTMS for Adolescent and Young Adult Depression
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
rTMS for Adolescents and Young Adults
rTMS for Adolescent and Young Adult Depression
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
Status: Archived
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
Status: Archived
Updated: 1/1/1970
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
Status: Archived
University of Arizona
mi
from
Tucson, AZ
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
Status: Archived
Updated: 1/1/1970
University of Arizona
mi
from
Tucson, AZ
This is a Study to Determine the Antidepressant Effects of AZD6765
An Investigation of the Antidepressant Effects of an NMDA Antagonist in Treatment-Resistant Major Depression
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
This is a Study to Determine the Antidepressant Effects of AZD6765
An Investigation of the Antidepressant Effects of an NMDA Antagonist in Treatment-Resistant Major Depression
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients
Feasibility and Efficacy of a Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients
Feasibility and Efficacy of a Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Treatment for Depressed Primary Care Patients
Community-Based Depression Care Management for Elderly Primary Care Patients
Status: Archived
Westchester Medical Group Practices
mi
from
White Plains, NY
Treatment for Depressed Primary Care Patients
Community-Based Depression Care Management for Elderly Primary Care Patients
Status: Archived
Updated: 1/1/1970
Westchester Medical Group Practices
mi
from
White Plains, NY
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Yale University School of Medicine
mi
from
New Haven, CT
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Updated: 1/1/1970
Yale University School of Medicine
mi
from
New Haven, CT
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Emory University
mi
from
Atlanta, GA
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Updated: 1/1/1970
Emory University
mi
from
Atlanta, GA
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Washington University
mi
from
St. Louis, MO
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Trustees of the University of Pennsylvania, Penn Cardiac Center at Mercer Bucks
mi
from
Yardley, PA
Comparison of Depression Interventions After Acute Coronary Syndrome
Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)
Status: Archived
Updated: 1/1/1970
Trustees of the University of Pennsylvania, Penn Cardiac Center at Mercer Bucks
mi
from
Yardley, PA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site 055
mi
from
Dothan, AL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 055
mi
from
Dothan, AL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site 065
mi
from
Highlands Ranch, CO
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 065
mi
from
Highlands Ranch, CO
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Boca Raton, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Boca Raton, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site 057
mi
from
Boca Raton, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 057
mi
from
Boca Raton, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site 064
mi
from
Gainesville, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 064
mi
from
Gainesville, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site 053
mi
from
Ocala, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 053
mi
from
Ocala, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Multiple Sclerosis Institute
mi
from
Philadelphia, PA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Multiple Sclerosis Institute
mi
from
Philadelphia, PA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site 059
mi
from
Winter Park, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 059
mi
from
Winter Park, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Atlanta, GA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Atlanta, GA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site 066
mi
from
Smyrna, GA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Flexible-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 066
mi
from
Smyrna, GA